UniProtKB/Swiss-Prot Q9BQI5: Variant p.Pro161Gln

SH3-containing GRB2-like protein 3-interacting protein 1
Gene: SGIP1
Feedback?

Variant information Variant position:

161 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Glutamine (Q) at position 161 (P161Q, p.Pro161Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (P) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Polymorphism:

Genetic variation in SGIP1 is associated with fat mass and SGIP1 may be a determinant of obesity-related traits. Additional information on the polymorphism described.
Other resources:

Links to websites of interest for the variant.

Variant rs17855645 [ dbSNP | Ensembl ]

Sequence information Variant position:

161 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

828 The length of the canonical sequence.
Location on the sequence:

ASIGNIALSPSPVRKSPRRS P GAIKRNLSSEEVARPRRSTP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         ASIGNIALSPSPVRKSPRRSPGAIKRNLSSEEVARPRRSTP

Mouse                         ASIGNIALSPSPVRKSPRRSPGAIKRNLSSEEVARPRRSTP

Rat                           ASIGNIALSPSPVRKSPRRSPGAIKRNLSSEEVARPRRSTP

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 828	SH3-containing GRB2-like protein 3-interacting protein 1
Region	143 – 205	Disordered
Modified residue	149 – 149	Phosphoserine
Modified residue	151 – 151	Phosphoserine
Modified residue	156 – 156	Phosphoserine
Modified residue	169 – 169	Phosphoserine
Modified residue	180 – 180	Phosphothreonine
Alternative sequence	154 – 161	Missing. In isoform 4 and isoform 5.

Literature citations
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3); VARIANTS GLN-161 AND GLU-575;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.